Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
26.79
-0.01 (-0.04%)
At close: Aug 14, 2026, 4:00 PM EDT
26.79
0.00 (-0.02%)
After-hours: Aug 14, 2026, 7:59 PM EDT
Pfizer Revenue
Pfizer had revenue of $15.03B in the quarter ending June 28, 2026, with 2.60% growth. This brings the company's revenue in the last twelve months to $63.70B, down -0.21% year-over-year. In the year 2025, Pfizer had annual revenue of $62.58B, down -1.65%.
Revenue (ttm)
$63.70B
Revenue Growth
-0.21%
P/S Ratio
2.40
Revenue / Employee
$849,280
Employees
75,000
Market Cap
152.69B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 62.58B | -1.05B | -1.65% |
| Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
| Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
| Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
| Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
| Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
| Dec 31, 2019 | 40.91B | 80.00M | 0.20% |
| Dec 31, 2018 | 40.83B | -11.72B | -22.31% |
| Dec 31, 2017 | 52.55B | -278.00M | -0.53% |
| Dec 31, 2016 | 52.82B | 3.97B | 8.13% |
| Dec 31, 2015 | 48.85B | -754.00M | -1.52% |
| Dec 31, 2014 | 49.61B | -1.98B | -3.84% |
| Dec 31, 2013 | 51.58B | -3.07B | -5.62% |
| Dec 31, 2012 | 54.66B | -6.38B | -10.45% |
| Dec 31, 2011 | 61.04B | -4.13B | -6.34% |
| Dec 31, 2010 | 65.17B | 15.90B | 32.26% |
| Dec 31, 2009 | 49.27B | 973.00M | 2.01% |
| Dec 31, 2008 | 48.30B | -122.00M | -0.25% |
| Dec 31, 2007 | 48.42B | 47.00M | 0.10% |
| Dec 31, 2006 | 48.37B | 966.00M | 2.04% |
| Dec 31, 2005 | 47.41B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Johnson & Johnson | 97.93B |
| Merck & Co. | 66.57B |
| AbbVie | 64.39B |
| AstraZeneca | 61.37B |
| Novartis AG | 56.69B |
| Sanofi | 55.89B |
| Novo Nordisk | 50.34B |
| Bristol-Myers Squibb Company | 49.19B |
PFE News
- 22 hours ago - Pfizer (PFE) CEO Buys $1 Million of Company Stock - TipRanks
- 23 hours ago - Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase - Barrons
- 1 day ago - Closed Pfizer biopharma facility in Everett gets a new lease on life - GeekWire
- 1 day ago - Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money - Fast Company
- 1 day ago - Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes - TipRanks
- 1 day ago - Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency - GlobeNewsWire
- 1 day ago - Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency - Business Wire
- 8 days ago - Pfizer price target lowered to $31 from $35 at Guggenheim - TheFly